Nektar Therapeutics (NKTR)

[stockguard]

www.horizonstudy.com

you have type 2 diabetes – and are currently using Lantus® – you are invited to see if you may qualify to participate in a new medical research study called the Exubera® Horizon Study. The purpose of the study is to determine if Exubera®, an approved inhaled insulin, works in controlling blood glucose levels when used with Lantus. Half of the study participants will receive Exubera, and the other half will receive an approved injectable form of mealtime insulin. Physicians right in your area are conducting the Exubera® Horizon Study.

Each individual will be evaluated to determine his or her eligibility. If you qualify, you’ll receive study medication– including Lantus and mealtime insulin – study-related medical exams, lab tests, and blood glucose testing supplies at no charge. Financial compensation for time and travel may also be available.